公开(公告)号：BG101328A

公开(公告)日：1997-08-29

申请号：BG10132897

申请日：1997-03-14

Applicant: BASF AG

Inventor： TREIBER HANS-JOERG ,  LUBISCH WILFRIED ,  BEHL BERTHOLD ,  HOFMANN HANS P

IPC: A61K31/495 ,  A61P9/00 ,  A61P25/00 ,  A61P25/08 ,  A61P25/24 ,  A61P25/26 ,  C07D487/04

Abstract: The invention relates to imidatoloquhoxalinons having the formula where R1, R2, R3, R4, R5, A & B have the meanings listed in the description, as well as to methods for their preparations. The new substances have good effect as glutamate antagonists and are suitable for using in the treatment of neurodegenerative diseases.

公开(公告)号：PL319406A1

公开(公告)日：1997-08-04

申请号：PL31940695

申请日：1995-09-19

Applicant: BASF AG

Inventor： TREIBER HANS-JOERG ,  LUBISCH WILFRIED ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/495 ,  A61P9/00 ,  A61P25/00 ,  A61P25/08 ,  A61P25/24 ,  A61P25/26 ,  C07D487/04

公开(公告)号：GR3023147T3

公开(公告)日：1997-07-30

申请号：GR970400809

申请日：1997-04-15

Applicant: BASF AG

Inventor： SCHLECKER RAINER ,  TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/505 ,  A61P25/02 ,  A61P25/20 ,  C07D487/04

Abstract: PCT No. PCT/EP93/03331 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 27, 1993 PCT Pub. No. WO94/13672 PCT Pub. Date Jun. 23, 1994Novel triazoloquinazolines of the formula I gs stated in the description, and their preparation are described. The compounds are suitable for controlling diseases.

公开(公告)号：NO971674D0

公开(公告)日：1997-04-11

申请号：NO971674

申请日：1997-04-11

Applicant: BASF AG

Inventor： LUBISCH WILFRIED ,  VIERLING MICHAEL ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/495 ,  A61P25/00 ,  A61P43/00 ,  C07D403/04

Abstract: PCT No. PCT/EP95/03902 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Oct. 2, 1995 PCT Pub. No. WO90/11922 PCT Pub. Date Apr. 25, 1996Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I I and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compounds are antagonists of the glutamate receptor subtypes and are thus suitable for controlling various diseases.

公开(公告)号：AT150023T

公开(公告)日：1997-03-15

申请号：AT94901898

申请日：1993-11-27

Applicant: BASF AG

Inventor： SCHLECKER RAINER ,  TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/505 ,  A61K31/55 ,  A61P9/10 ,  A61P25/00 ,  A61P25/06 ,  A61P25/08 ,  A61P25/16 ,  A61P25/24 ,  A61P25/28 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07D491/044 ,  C07D491/147 ,  C07D495/14 ,  C07D249/00 ,  C07D239/00

Abstract: Triazolopyrimidines of the formula I where A, D and X have the meanings stated in the description, and their preparation are described. The novel compounds are suitable for controlling diseases.

公开(公告)号：AT149167T

公开(公告)日：1997-03-15

申请号：AT94901897

申请日：1993-11-27

Applicant: BASF AG

Inventor： SCHLECKER RAINER ,  TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/505 ,  A61P25/02 ,  A61P25/20 ,  C07D487/04 ,  C07D249/00 ,  C07D239/00

Abstract: PCT No. PCT/EP93/03331 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 27, 1993 PCT Pub. No. WO94/13672 PCT Pub. Date Jun. 23, 1994Novel triazoloquinazolines of the formula I gs stated in the description, and their preparation are described. The compounds are suitable for controlling diseases.

公开(公告)号：AU674909B2

公开(公告)日：1997-01-16

申请号：AU5628494

申请日：1993-11-27

Applicant: BASF AG

Inventor： SCHLECKER RAINER ,  TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/505 ,  A61P25/02 ,  A61P25/20 ,  C07D487/04

Abstract: PCT No. PCT/EP93/03331 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 27, 1993 PCT Pub. No. WO94/13672 PCT Pub. Date Jun. 23, 1994Novel triazoloquinazolines of the formula I gs stated in the description, and their preparation are described. The compounds are suitable for controlling diseases.

公开(公告)号：ZA955128B

公开(公告)日：1996-12-23

申请号：ZA955128

申请日：1995-06-21

Applicant: BASF AG

Inventor： LUBISCH WILFRIED ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: C07D241/44 ,  A61K31/495 ,  A61P25/00 ,  A61P25/08 ,  A61P25/24 ,  A61P25/26 ,  C07D20060101 ,  C07D241/54 ,  C07D403/04 ,  C07D ,  A61K

Abstract: PCT No. PCT/EP95/02324 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 16, 1995 PCT Pub. No. WO95/35289 PCT Pub. Date Dec. 28, 1995Novel amido-quinoxalinediones of the formula I where R1-R5, n and m have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.

公开(公告)号：AT144497T

公开(公告)日：1996-11-15

申请号：AT93912912

申请日：1993-06-08

Applicant: BASF AG

Inventor： STEINER GERD ,  UNGER LILIANE ,  BEHL BERTHOLD ,  TESCHENDORF HANS-JUERGEN

IPC: C07D401/04 ,  A61K31/40 ,  A61K31/403 ,  A61K31/4427 ,  A61K31/4433 ,  A61K31/4439 ,  A61K31/445 ,  A61P25/00 ,  A61P25/02 ,  A61P25/20 ,  A61P43/00 ,  C07D209/52 ,  C07D409/04

公开(公告)号：AU671130B2

公开(公告)日：1996-08-15

申请号：AU4323893

申请日：1993-06-08

Applicant: BASF AG

Inventor： STEINER GERD ,  UNGER LILIANE ,  BEHL BERTHOLD ,  TESCHENDORF HANS-JUERGEN ,  MUNSCHAUER RAINER

IPC: C07D513/04 ,  A61K20060101 ,  A61K31/33 ,  A61K31/395 ,  A61K31/40 ,  A61K31/4045 ,  A61K31/4184 ,  A61K31/505 ,  A61K31/506 ,  A61K31/513 ,  A61K31/517 ,  A61K31/519 ,  A61K31/54 ,  A61K31/542 ,  A61P25/00 ,  A61P25/20 ,  A61P25/22 ,  A61P25/24 ,  A61P43/00 ,  C07D20060101 ,  C07D207/00 ,  C07D209/02 ,  C07D209/52 ,  C07D221/00 ,  C07D239/00 ,  C07D401/04 ,  C07D401/06 ,  C07D401/14 ,  C07D403/00 ,  C07D403/04 ,  C07D403/06 ,  C07D403/14 ,  C07D409/04 ,  C07D409/06 ,  C07D409/14 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04

Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.